These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24097168)

  • 41. Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study.
    Kowey PR; Crijns HJ; Aliot EM; Capucci A; Kulakowski P; Radzik D; Roy D; Connolly SJ; Hohnloser SH;
    Circulation; 2011 Dec; 124(24):2649-60. PubMed ID: 22082672
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone.
    Connolly SJ; Gent M; Roberts RS; Dorian P; Roy D; Sheldon RS; Mitchell LB; Green MS; Klein GJ; O'Brien B
    Circulation; 2000 Mar; 101(11):1297-302. PubMed ID: 10725290
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Management of ventricular tachycardia in heart failure.
    Baher A; Valderrabano M
    Methodist Debakey Cardiovasc J; 2013; 9(1):20-5. PubMed ID: 23519088
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial.
    Klein RC; Raitt MH; Wilkoff BL; Beckman KJ; Coromilas J; Wyse DG; Friedman PL; Martins JB; Epstein AE; Hallstrom AP; Ledingham RB; Belco KM; Greene HL;
    J Cardiovasc Electrophysiol; 2003 Sep; 14(9):940-8. PubMed ID: 12950538
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of amiodarone in the era of the implantable cardioverter defibrillator.
    Dorian P; Mangat I
    J Cardiovasc Electrophysiol; 2003 Sep; 14(9 Suppl):S78-81. PubMed ID: 12950525
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification and management of ventricular tachycardia.
    Naik N; Talwar KK
    J Indian Med Assoc; 2003 Feb; 101(2):62-5, 95. PubMed ID: 12841484
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
    Connolly SJ; Hallstrom AP; Cappato R; Schron EB; Kuck KH; Zipes DP; Greene HL; Boczor S; Domanski M; Follmann D; Gent M; Roberts RS
    Eur Heart J; 2000 Dec; 21(24):2071-8. PubMed ID: 11102258
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increase in ventricular tachycardia frequency after biventricular implantable cardioverter defibrillator upgrade.
    Guerra JM; Wu J; Miller JM; Groh WJ
    J Cardiovasc Electrophysiol; 2003 Nov; 14(11):1245-7. PubMed ID: 14678142
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Delayed detection of stable ventricular tachycardia in a dual-chamber implantable cardioverter defibrillator: what is the mechanism?
    Strohmer B; Schernthaner C; Pichler M
    J Cardiovasc Electrophysiol; 2004 Feb; 15(2):244-6. PubMed ID: 15028059
    [No Abstract]   [Full Text] [Related]  

  • 50. Drugs for ventricular arrhythmias in the era of the implantable cardioverter defibrillator.
    Peters NS
    Eur Heart J; 1999 Mar; 20(5):321-3. PubMed ID: 10206376
    [No Abstract]   [Full Text] [Related]  

  • 51. Success of chronic defibrillation and the role of antiarrhythmic drugs with the automatic implantable cardioverter/defibrillator.
    Guarnieri T; Levine JH; Veltri EP; Griffith LS; Watkins L; Juanteguy J; Mower MM; Mirowski M
    Am J Cardiol; 1987 Nov; 60(13):1061-4. PubMed ID: 3673907
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Unexpectedly high defibrillation thresholds in an active can implantable cardioverter defibrillator system.
    Rao A; Reynolds DW; Beckman KJ
    Pacing Clin Electrophysiol; 2001 Jul; 24(7):1168-9. PubMed ID: 11475837
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical predictors of defibrillation energy requirements in patients treated with a nonthoracotomy defibrillator system. The ResQ Investigators.
    Strickberger SA; Brownstein SL; Wilkoff BL; Zinner AJ
    Am Heart J; 1996 Feb; 131(2):257-60. PubMed ID: 8579017
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A patient with recurrent atrial fibrillation and monomorphic ventricular tachycardia treated successfully with dronedarone.
    Fink A; Duray GZ; Hohnloser SH
    Europace; 2011 Feb; 13(2):284-5. PubMed ID: 20965881
    [No Abstract]   [Full Text] [Related]  

  • 55. Successful management of ventricular fibrillation and ventricular tachycardia using defibrillation and intravenous amiodarone therapy in a cat.
    Berlin N; Ohad DG; Maiorkis I; Kelmer E
    J Vet Emerg Crit Care (San Antonio); 2020 Jul; 30(4):474-480. PubMed ID: 32400960
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Arrhythmic storm induced by AICD discharge in a patient with catecholaminergic polymorphic ventricular tachycardia].
    Palanca V; Quesada A; Trigo A; Jiménez J
    Rev Esp Cardiol; 2006 Oct; 59(10):1079-80. PubMed ID: 17125720
    [No Abstract]   [Full Text] [Related]  

  • 57. A comparison of long-standing implantable cardioverter-defibrillator patients with and without appropriate therapy for ventricular arrhythmias: impact of a widening QRS.
    Dizon J; Chen K; Dizon S; Biviano A; Whang W; Ehlert F; Vazquez J; Nazif T; Garan H
    Europace; 2011 Jan; 13(1):77-81. PubMed ID: 21149513
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Subcutaneous Implantable Cardioverter-Defibrillator Implantation Without Defibrillation Testing.
    Miller MA; Palaniswamy C; Dukkipati SR; Balulad S; Smietana J; Vigdor A; Koruth JS; Choudry S; Whang W; Reddy VY
    J Am Coll Cardiol; 2017 Jun; 69(25):3118-3119. PubMed ID: 28641801
    [No Abstract]   [Full Text] [Related]  

  • 59. Unresectable cardiac pseudoneoplasms causing ventricular tachycardia.
    Malaczynska-Rajpold K; Blaszyk K; Kurzawa P; Pyda M; Wachowiak-Baszynska H; Mularek-Kubzdela T; Grajek S
    Cardiovasc Pathol; 2014; 23(6):372-5. PubMed ID: 25174794
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Arrhythmogenic Right Ventricular Cardiomyopathy: An Exuberant Case Affecting Both Ventricles.
    Gomes AC; Lopes LR; Cruz I; Almeida AR; Miranda R; Almeida S; Brandão L; Pereira H
    Circ Cardiovasc Imaging; 2020 Sep; 13(9):e010243. PubMed ID: 32873069
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.